DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Janus kinase 3
Janus kinase 3
Promoter Janus Kinase 3 Proximal Characterization and Analysis Of
HCC and Cancer Mutated Genes Summarized in the Literature Gene Symbol Gene Name References*
Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
Crystal Structure of the Jak3 Kinase Domain in Complex with a Staurosporine Analog
JAK3 Deficiency, (SCID T-B+)
Supplementary Table 2
Beyond Traditional Morphological Characterization of Lung
Advances in the Inhibitors of Janus Kinase
Hirbe AC, Kaushal M, Sharma MK
Myeloid Innate Immunity Mouse Vapril2018
Jak3 Is Involved in CCR7-Dependent Migration and Invasion in Metastatic Squamous Cell Carcinoma of the Head and Neck
Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
Reviewed by HLDA1
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development
Unexpected and Variable Phenotypes in a Family with JAK3 Deficiency
STAM2, a New Member of the STAM Family, Binding to the Janus Kinases
A Potential Role for Targeted Therapy in a Subset of Metastasizing Adnexal Carcinomas
Small Molecule
Top View
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
The Role of Janus Kinase 3 in CD4+ T Cell Homeostasis and Function: a Dissertation
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK
Investigation of the Role of Jak2 in Socs1-Mediated Granulocyte-Macrophage Colony-Stimulating Factor Receptor Turnover
List of Actionable Genes and Potential Matched Therapy
A Requirement for Y841 in Jak3 Enzymatic Activity and Hematopoietic Cancers George Steven Martinez University of Texas at El Paso,
[email protected]
Identification of an Egfrviii-JNK2-HGF/C-Met–Signaling Axis Required for Intercellular Crosstalk and Glioblastoma Multiforme Cell Invasion S
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
JAK3 Gene Janus Kinase 3
Interleukin-12 Bypasses Common Gamma-Chain Signalling in Emergency Natural Killer Cell Lymphopoiesis
TYK2: an Upstream Kinase of Stats in Cancer
Open Access in Vivo Anti-Cancer Activity of A
JAK: No Longer ‘Just Another Kinase’
Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-Cell
JAK/STAT Signaling
Differential Regulation of Janus Kinase 3 (JAK3) in Bovine Preovulatory
JAK Kinases in Health and Disease: an Update Arian Laurence1, Marko Pesu2,3, Olli Silvennoinen2,3 and John O’Shea*,1
IL-4 and IL-13 Activate the JAK2 Tyrosine Kinase and Stat6 In
JAK2V617F-Positive Myeloproliferative Neoplasms
Ptk Array Lay-Out
Targeting the Jak/STAT Pathway for Immunosuppression J J O’Shea
Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder
Drug Discovery at Scale
Jaks and Stats As Therapeutic Targets
Discovery of a Highly Selective JAK3 Inhibitor for the Treatment Of
Structure-Based Design of Specific Inhibitors of Janus Kinase 3 As Apoptosis-Inducing Antileukemic Agents1
Human Kinase Library II
Oclacitinib (APOQUEL) Is a Novel Janus Kinase Inhibitor with Activity
Rethinking JAK2 Inhibition: Towards Novel Strategies of More Specific and Versatile Janus Kinase Inhibition
Identifying the Role of Janus Kinase 1 in Mammary Gland Development and Breast Cancer
Spotlight Review
Active Kinase Manual
STAT Signaling in Hematological Malignancies
Supplementary Table 1. a Full List of Cancer Genes
Janus Kinase Inhibitors Mechanisms of Action
Myeloid Innate Immunity Human Vapril2018